Education
About Us
Working with TipRanks
Follow Us
MARC GRASSO Insider Profile
4 Followers
MARC GRASSO, CFO, CBO at Kura Oncology, holds 296.07K shares in Alector (Ticker: ALEC), holds 21.90K shares in Kura Oncology (Ticker: KURA), holds ― shares in Kyverna Therapeutics, Inc. (Ticker: KYTX). Most recently, MARC GRASSO Sold ― shares of Alector on Jun 04, 2025 for an estimated value of 21.93K.
Profitable Transactions
8 out of 10 Profitable Transactions
Average Return
+31.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that MARC GRASSO holds in companies
Most Profitable Insider Trade
The most profitable trade made by MARC GRASSO
MARC GRASSO's Trading History
Kura Oncology
Jan 28, 2022
CFO, CBO
Uninformative Buy
―
$137.97K
Alector
Jun 04, 2025
CFO
Informative Sell
21.93K
$473.72K
Kyverna Therapeutics, Inc.
―
Chief Financial Officer
―
―
List of latest transactions for each holding click on a transaction to see MARC GRASSO's performance on stock
You May Also Like
MARC GRASSO insider profile FAQ
What is the percentage of profitable transactions made by MARC GRASSO?
The percentage of profitable transactions made by MARC GRASSO is 80%.
What is the average return per transaction made by MARC GRASSO?
The average return per transaction made by MARC GRASSO is 31.80%.
What stocks does MARC GRASSO hold?
MARC GRASSO holds: KURA, ALEC, KYTX stocks.
What was MARC GRASSO’s latest transaction?
MARC GRASSO latest transaction was an Informative Sell of $21.93K.
What was MARC GRASSO's most profitable transaction?
MARC GRASSO’s most profitable transaction was an Informative Sell of ALEC stock on March 5, 2024. The return on the trade was 76.90%.
What is MARC GRASSO's role in Kura Oncology?
MARC GRASSO's role in Kura Oncology is CFO, CBO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.